Bash Biotech
Bash Biotech is an innovative biopharmaceutical company focused on developing efficient treatment strategies for neurological and kidney diseases. They leverage artificial intelligence and systems biology to study host-microbiome interactions, integrating multi-omics data to identify drug targets and biomarkers. The company also engages in drug repositioning to find new uses for existing drugs and predict potential side effects. Their platforms include InetModels, the Human Gut Microbiome Atlas, and a Drug Repositioning Platform. Bash Biotech has ongoing programs for Chronic Kidney Disease, Kidney Cancer, Alzheimer's Disease, and Parkinson's Disease, with several candidates in preclinical stages.
Bash Biotech
Bash Biotech is an innovative biopharmaceutical company focused on developing efficient treatment strategies for neurological and kidney diseases. They leverage artificial intelligence and systems biology to study host-microbiome interactions, integrating multi-omics data to identify drug targets and biomarkers. The company also engages in drug repositioning to find new uses for existing drugs and predict potential side effects. Their platforms include InetModels, the Human Gut Microbiome Atlas, and a Drug Repositioning Platform. Bash Biotech has ongoing programs for Chronic Kidney Disease, Kidney Cancer, Alzheimer's Disease, and Parkinson's Disease, with several candidates in preclinical stages.